Cuba begins clinical trial of its second COVID-19 vaccine candidate
Cuba began a new clinical trial aimed at curing the COVID-19 disease, produced by the SARS-CoV-2 virus, which to date has caused more than 40 million infections in the world. This new “vaccine candidate” was registered by the Finlay Vaccine Institute under the name of SOBERANA 01A, which today will start Read more